School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AJ, UK.
Dept of Physiology, Tokyo Medical University, Tokyo, Japan.
Cell Calcium. 2021 Jan;93:102326. doi: 10.1016/j.ceca.2020.102326. Epub 2020 Nov 30.
SUMOylation is an important post-translational modification process involving covalent attachment of SUMO (Small Ubiquitin-like MOdifier) protein to target proteins. Here, we investigated the potential for SUMO-1 protein to modulate the function of the Ca2.2 (N-type) voltage-gated calcium channel (VGCC), a protein vital for presynaptic neurotransmitter release. Co-expression of SUMO-1, but not the conjugation-deficient mutant SUMO-1ΔGG, increased heterologously-expressed Ca2.2 Ca current density, an effect potentiated by the conjugating enzyme Ubc9. Expression of sentrin-specific protease (SENP)-1 or Ubc9 alone, had no effect on recombinant Ca2.2 channels. Co-expression of SUMO-1 and Ubc9 caused an increase in whole-cell maximal conductance (G) and a hyperpolarizing shift in the midpoint of activation (V). Mutation of all five Ca2.2 lysine residues to arginine within the five highest probability (>65 %) SUMOylation consensus motifs (SCMs) (construct Ca2.2-Δ5KR), produced a loss-of-function mutant. Mutagenesis of selected individual lysine residues identified K394, but not K951, as a key residue for SUMO-1-mediated increase in Ca2.2 Ca current density. In synaptically-coupled superior cervical ganglion (SCG) neurons, SUMO-1 protein was distributed throughout the cell body, axons and dendrites and presumptive presynaptic terminals, whilst SUMO-1ΔGG protein was largely confined to the cell body, in particular, the nucleus. SUMO-1 expression caused increases in paired excitatory postsynaptic potential (EPSP) ratio at short (20-120 ms) inter-stimuli intervals in comparison to SUMO-1ΔGG, consistent with an increase in residual presynaptic Ca current and an increase in release probability of synaptic vesicles. Together, these data provide evidence for Ca2.2 VGCCs as novel targets for SUMOylation pathways.
SUMOylation 是一种重要的翻译后修饰过程,涉及 SUMO(小泛素样修饰物)蛋白与靶蛋白的共价连接。在这里,我们研究了 SUMO-1 蛋白调节 Ca2.2(N 型)电压门控钙通道(VGCC)功能的潜力,VGCC 对突触前神经递质释放至关重要。SUMO-1 的共表达,但不是缀合缺陷突变 SUMO-1ΔGG,增加了异源表达的 Ca2.2 Ca 电流密度,这种效应被连接酶 Ubc9 增强。单独表达 sentrin 特异性蛋白酶(SENP)-1 或 Ubc9 对重组 Ca2.2 通道没有影响。SUMO-1 和 Ubc9 的共表达导致全细胞最大电导(G)增加和激活中点超极化(V)。在五个最高概率(>65%)SUMOylation 共有序列模体(SCM)内的所有五个 Ca2.2 赖氨酸残基突变为精氨酸(构建体 Ca2.2-Δ5KR),产生了功能丧失突变体。对选定的单个赖氨酸残基的突变鉴定出 K394,但不是 K951,是 SUMO-1 介导的 Ca2.2 Ca 电流密度增加的关键残基。在突触偶联的颈上神经节(SCG)神经元中,SUMO-1 蛋白分布在细胞体、轴突和树突以及假定的突触前末端,而 SUMO-1ΔGG 蛋白主要局限于细胞体,特别是核。与 SUMO-1ΔGG 相比,SUMO-1 表达导致短(20-120 ms)刺激间隔时的成对兴奋性突触后电位(EPSP)比率增加,这与残留的突触前 Ca 电流增加和突触小泡释放概率增加一致。总之,这些数据为 Ca2.2 VGCCs 作为 SUMOylation 途径的新靶标提供了证据。